Cancer BiologyeLifePeer-reviewed
Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer
Phaedra C. Ghazi, Kayla T. O’Toole, Sanjana Srinivas Boggaram…·Martin McMahon
This study shows that combining ULK1/2 inhibition with KRASG12C inhibitors reduces lung cancer growth in preclinical models.
40 citationstop 1%